Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action: 4th Communication: Influence on experimentally induced ventricular arrhythmia in dogs

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 5, 1999, Pages 420-426

  Yoshimura, Akira ^a   Yoshioka, Kimitomo ^a   Hino, Masataka ^a   Sugawara, Hiromi ^a   Sakato, Mitsuo ^a   Endoh, Masao ^b  

^a ZENYAKU KOGYO CO LTD   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

4,5 Dihydro 6 1 2 hydroxy 2 (4 cyanophenyl)ethyl 1,2,5,6 tetrahydropyrido 4 yl pyridazin 3(2H) one; Cardiotonic agent; SCH00013, arrhythmogenicity, optical isomers; Ventricular arrhythmia; Vesnarinone

Indexed keywords

4,5 DIHYDRO 6 [1 [2 HYDROXY 2 (4 CYANOPHENYL)ETHYL] 1,2,5,6 TETRAHYDROPYRIDO 4 YL]PYRIDAZIN 3(2H) ONE; ADRENALIN; CALCIUM SENSITIZER; CARDIOTONIC AGENT; DIGITALIS; PIPERANOMETOZINE; PYRIDAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BIOEQUIVALENCE; BLOOD PRESSURE; CORONARY ARTERY LIGATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RESEARCH; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; ISOMER; NONHUMAN;

EID: 0032977693     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300437     Document Type: Article

References (20)

1. Katz, A. M., Circulation 73 (Suppl. III), III-84 (1986)
2. Nielsen-Kudsk, J. E., Aldershvile, J., J. Cardiovasc. Pharmacol. 26 (Suppl. I), S77 (1995)
3. Sugawara, H., Endoh, M., J. Pharmacol. Exp. Ther. 287, 214 (1998)
4. Hino, M., Sugawara, H., Yoshimura, A. et al., Arzneim.-Forsch./Drug Res. 49 (1), 398 (1999)
5. Yoshimura, A., Koide, Y., Yoshioka, K. et al., Arzneim.-Forsch./Drug Res. 49 (I), 407 (1999)
6. Taira, N., Endoh, M., Iijima, T. et al., Arzneim.-Forsch./Drug Res. 34 (I), 347 (1984)
7. Rapundalo, S. T., Lathrop, D. A., Harrison, S. A. et al., Naunyn-Schmiedeberg's Arch. Pharmacol. 338, 692 (1988)
8. Lathrop, D. A., Varró, A., Schwartz, A., Eur. J. Pharmacol. 164, 487 (1989)
9. Yanagisawa, T., Ishii, K., Taira, N., J. Cardiovasc. Pharmacol. 10, 47 (1987)
10. Miyazaki, S., Sasayama, S., Nakamura, Y. et al., J. Cardiovasc. Pharmacol. 8, 14 (1986)
11. Sugawara, H., Hino, M., Yoshimura, A. et al., Arzneim.-Forsch./Drug Res. 49 (I), 412 (1999)
12. Hashimoto, K., Mitsuhashi, H., Br. J. Pharmacol. 88, 915 (1986)
13. Hashimoto, K., Ishii, M., Komori, S. et al., Heart Vessels 1, 29 (1985)
14. Hashimoto, K., Haruno, A., Matsuzaki, T. et al., Asia Pac. J. Pharmacol. 6, 127 (1991)
15. Hashimoto, K., Haruno, A., Hirasawa, A. et al., Jpn. J. Pharmacol. 68, 1 (1995)
16. Xue, Y. X., Eto, K., Yasuki, A. Y. et al., Jpn. J. Pharmacol. 70, 129 (1996)
17. Chen, J., Xue, Y. X., Eto, K. et al., J. Cardiovasc. Pharmacol. 28, 576 (1996)
18. Shibuya, T., Hashimoto, K., Imai, S., J. Cardiovasc. Pharmacol. 5, 538 (1983)
19. Hashimoto, K., Shibuya, T., Imai, S., Jpn. J. Pharmacol. 33, 1035 (1983)
20. Awaji, T., Wu, Z. J., Hashimoto, K., J. Cardiovasc. Pharmacol. 26, 869 (1995)